failure to respond or late response
on 01 Apr 2022
Last Applicant/ Owned by
CHIVERS WAY, HISTON
CAMBRIDGE
GB
CB249BZ
Serial Number
87771644 filed on 26th Jan 2018
Registration Number
N/A
Correspondent Address
Michael T. Olsen
Filing Basis
1. intent to use
Disclaimer
NO DATA
Scientific and technological services and research and design relating thereto, namely, scientific research in the field of cannabinoid-based medicines, research on the subject of pharmaceuticals, and pharmaceutical drug development services, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahRead More
Scientific and technological services and research and design relating thereto, namely, scientific research in the field of cannabinoid-based medicines, research on the subject of pharmaceuticals, and pharmaceutical drug development services, all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical research and development services all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; research, testing and development of pharmaceutical and veterinary preparations all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; biological, clinical and medical research all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; conducting clinical trials for others all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; chemical analysis all involving only a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; information, advisory and consultancy services in relation to all of the aforesaid services
Providing online non-downloadable electronic publications in the nature of newsletters, journals, and books in the field of cannabinoid-based medicines; arranging, conducting and organisation of educational conferences, congresses, seminars and symposiums in the field of cannabinoid-based medicines; information, advisory and consultancy services in relation to all of the aforesaid services
Financing services; providing funding for investigators, inventors, universities, research institutes and other academic entities, namely, financing services and providing venture capital, development capital, private equity and investment funding; funding of research and product development, namely, financing services and providing venture capital, development capital, private equity and investment funding; information, advisory and consultancy services in relation to all of the aforesaid services
No 87771644
No Service Mark
No
Yes
No
No
Yes
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 01st Apr 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 01st Apr 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 15th Sep 2021 | NON-FINAL ACTION WRITTEN |
| 15th Sep 2021 | NON-FINAL ACTION E-MAILED |
| 15th Sep 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 15th Sep 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 15th Sep 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 15th Sep 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 15th Sep 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 18th Aug 2021 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
